Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Surgical and interventional devices / Hospital operating-room surgical and interventional device suites

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Hospital operating-room surgical and interventional device suites

Devices and consumables bought by hospital OR/cath-lab/endoscopy departments for open and minimally invasive procedures: surgical instruments, energy devices, staplers, sutures, imaging-guided navigation, endoscopy towers, interventional radiology and electrophysiology catheters, ablation and access devices, plus the disposable consumables attached to them. Buyer is the hospital department or perioperative value-analysis committee; job is to complete procedures safely, on time, within budget.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
80 /100
for B2B sellers
Evidence
not sized
2 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Hospitals (tertiary and community hospital OR, cath lab, endoscopy, IR and EP departments)
Buying centre
Perioperative value-analysis committee with department chair, surgeon/physician champion, clinical engineering, contracting and procurement; GPO and IDN influence at system level
Buying triggers
  • Procedure volume growth and operating-room time pressure
  • Hospital capital budget cycle and replacement of ageing installed base
  • Migration of cases to minimally invasive and robotic techniques
  • Bundled-payment and cost-per-case targets
  • New interventional cardiology and structural heart procedure indications
Pains
  • Fragmented purchasing across departments and inconsistent standardization
  • Capital equipment utilisation below target with high maintenance cost
  • Training and credentialing burden for new platforms
  • Reimbursement cuts and supply-chain disruption on disposables
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability4
Growth4

How this was sized

Not sized yet

No source sizes the surgical/interventional device segment directly. Source [6] states surgical, endoscopy and robotic systems are the largest device type at 31.00% of a USD 620bn 2025 global medical device market, implying roughly USD 192bn for 2025 and about USD 200bn for 2026 at the same 6.0% CAGR. Applying the 31% share to the 2026 global range of USD 576.9bn (Statista, [4]) to USD 640bn ([4]) gives USD 179bn-198bn for 2026, but that share bundles capital systems and consumables and is not a hospital-only figure. Bottom-up: hospital share of global surgical/interventional spend assumed at 70-80% (ambulatory centres and practices take the remainder), giving USD 125bn-158bn for 2026. Low confidence: the 31% device-type share is a single secondary citation and the hospital/ASC split is an assumption, not a sourced figure.

Alongside it in Surgical and interventional devices

// Sell into Hospital operating-room surgical and interventional device suites

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.